Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Approved ALK inhibitors may provide pain relief

July 6, 2022

Novel dual RAGE/SERT inhibitor shows promise as treatment of AD with comorbid depression

July 6, 2022

Novel Alzheimer's disease model lacking interaction between FKBP51 and HSP90 generated

July 6, 2022

ACT-02 improves neurodegeneration in mouse model of PD

July 5, 2022

Mindset Pharma discovers 5-HT2A receptor agonists

July 5, 2022

First female-specific Alzheimer's risk gene found

July 4, 2022

PXL-065 demonstrates efficacy in preclinical models of ALD

July 4, 2022

Scripps Research Institute, Vova Ida Therapeutics patent compounds for treating neurodegeneration

July 4, 2022

FKBP51 blockade ameliorates cognitive function during obesity

July 4, 2022

ENT1 inhibitor reverses sporadic Alzheimer's disease in mice

July 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...